{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T14:21:49Z","timestamp":1789568509193,"version":"build-2803163510"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T00:00:00Z","timestamp":1684195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T00:00:00Z","timestamp":1684195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"European Union\u2019s Horizon 2020","award":["754517"],"award-info":[{"award-number":["754517"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Microglial activation contributes to both inflammatory damage and repair in experimental ischemic stroke. However, because of the logistical challenges, there have been few clinical imaging studies directly describing inflammatory activation and its resolution after stroke. The purpose of our pilot study was to describe the spatio-temporal profile of brain inflammation after stroke using 18kD translocator protein (TSPO) positron emission tomography (PET) with magnetic resonance (MR) co-registration in the subacute and chronic stage after stroke.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Three patients underwent magnetic resonance imaging (MRI) and PET scans with TSPO ligand [\n                      <jats:sup>11<\/jats:sup>\n                      C]PBR28 15\u2009\u00b1\u20093 and 90\u2009\u00b1\u20097\u00a0days after an ischaemic stroke. Regions of interest (ROI) were defined on MRI images and applied to the dynamic PET data to derive regional time-activity curves. Regional uptake was quantified as standardised uptake values (SUV) over 60 to 90\u00a0min post-injection. ROI analysis was applied to identify binding in the infarct, and in frontal, temporal, parietal, and occipital lobes and cerebellum excluding the infarcted area.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The mean age of participants was 56\u2009\u00b1\u200920.4\u00a0years and mean infarct volume was 17.9\u2009\u00b1\u200918.1\u00a0ml. [\n                      <jats:sup>11<\/jats:sup>\n                      C]PBR28 showed increased tracer signal in the infarcted area compared to non-infarcted areas of the brain in the subacute phase of stroke (Patient 1 SUV 1.81; Patient 2 SUV 1.15; Patient 3 SUV 1.64). [\n                      <jats:sup>11<\/jats:sup>\n                      C]PBR28 uptake returned to the level of non-infarcted areas at 90\u00a0days Patient 1 SUV 0.99; Patient 3 SUV 0.80). No additional upregulation was detected elsewhere at either time point.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The neuroinflammatory reaction after ischaemic stroke is limited in time and circumscribed in space suggesting that post-ischaemic inflammation is tightly controlled but regulatory mechanisms.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12883-023-03178-7","type":"journal-article","created":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T07:02:27Z","timestamp":1684220547000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Time course of neuroinflammation after human stroke \u2013 a pilot study using co-registered PET and MRI"],"prefix":"10.1186","volume":"23","author":[{"given":"Lucio","family":"D\u2019Anna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Searle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Matthews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Veltkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,16]]},"reference":[{"key":"3178_CR1","doi-asserted-by":"publisher","unstructured":"Shichita T, Sakaguchi R, Suzuki M, et al. Post-Ischemic Inflammation in the Brain. Front Immunol. 3. Epub ahead of print 2012. https:\/\/doi.org\/10.3389\/fimmu.2012.00132.","DOI":"10.3389\/fimmu.2012.00132"},{"key":"3178_CR2","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1093\/brain\/awr008","volume":"134","author":"A Liesz","year":"2011","unstructured":"Liesz A, Zhou W, Mracsk\u00f3 \u00c9, et al. Inhibition of lymphocyte trafficking shields the brain against deleterious neuroinflammation after stroke. Brain. 2011;134:704\u201320.","journal-title":"Brain"},{"key":"3178_CR3","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S0166-2236(99)01401-0","volume":"22","author":"U Dirnagl","year":"1999","unstructured":"Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 1999;22:391\u20137.","journal-title":"Trends Neurosci"},{"key":"3178_CR4","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/nm.2399","volume":"17","author":"C Iadecola","year":"2011","unstructured":"Iadecola C, Anrather J. The immunology of stroke: from mechanisms to translation. Nat Med. 2011;17:796\u2013808.","journal-title":"Nat Med"},{"key":"3178_CR5","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/j.1747-4949.2012.00839.x","volume":"7","author":"C Xing","year":"2012","unstructured":"Xing C, Arai K, Lo EH, et al. Pathophysiologic Cascades in Ischemic Stroke. Int J Stroke. 2012;7:378\u201385.","journal-title":"Int J Stroke"},{"key":"3178_CR6","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12974-019-1516-2","volume":"16","author":"RL Jayaraj","year":"2019","unstructured":"Jayaraj RL, Azimullah S, Beiram R, et al. Neuroinflammation: friend and foe for ischemic stroke. J Neuroinflammation. 2019;16:142.","journal-title":"J Neuroinflammation"},{"key":"3178_CR7","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s13311-016-0458-y","volume":"13","author":"R Veltkamp","year":"2016","unstructured":"Veltkamp R, Gill D. Clinical Trials of Immunomodulation in Ischemic Stroke. Neurotherapeutics. 2016;13:791\u2013800.","journal-title":"Neurotherapeutics"},{"key":"3178_CR8","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s13139-017-0475-8","volume":"51","author":"MdM Alam","year":"2017","unstructured":"Alam MdM, Lee J, Lee S-Y. Recent progress in the development of TSPO PET ligands for Neuroinflammation Imaging in Neurological Diseases. Nucl Med Mol Imaging. 2017;51:283\u201396.","journal-title":"Nucl Med Mol Imaging"},{"key":"3178_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/9845123","volume":"2018","author":"W-H Chen","year":"2018","unstructured":"Chen W-H, Yeh H-L, Tsao C-W, et al. Plasma translocator protein levels and outcomes of acute ischemic stroke: a pilot study. Dis Markers. 2018;2018:1\u20137.","journal-title":"Dis Markers"},{"key":"3178_CR10","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.drudis.2010.08.012","volume":"15","author":"PJ Schweitzer","year":"2010","unstructured":"Schweitzer PJ, Fallon BA, Mann JJ, et al. PET tracers for the peripheral benzodiazepine receptor and uses thereof. Drug Discov Today. 2010;15:933\u201342.","journal-title":"Drug Discov Today"},{"key":"3178_CR11","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1021\/bc300666f","volume":"24","author":"A Trapani","year":"2013","unstructured":"Trapani A, Palazzo C, de Candia M, et al. Targeting of the translocator protein 18 kDa (TSPO): a valuable approach for nuclear and optical imaging of activated microglia. Bioconjug Chem. 2013;24:1415\u201328.","journal-title":"Bioconjug Chem"},{"key":"3178_CR12","doi-asserted-by":"crossref","unstructured":"Luus C, Hanani R, Reynolds A, et al. The development of PET radioligands for imaging the translocator protein (18\u2009kDa): What have we learned?. J Labelled Comp Radiopharm. 2010;53(7):501\u201310.","DOI":"10.1002\/jlcr.1752"},{"key":"3178_CR13","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1002\/jlcr.2580211012","volume":"21","author":"R Camsonne","year":"1984","unstructured":"Camsonne R, Crouzel C, Comar D, et al. Synthesis of N-(11C) methyl, N-(methyl-1 propyl), (chloro-2 phenyl)-1 isoquinoleine carboxamide-3 (PK 11195): a new ligand for peripheral benzodiazepine receptors. J Labelled Comp Radiopharm. 1984;21:985\u201391.","journal-title":"J Labelled Comp Radiopharm"},{"key":"3178_CR14","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1097\/00001756-200009110-00025","volume":"11","author":"A Gerhard","year":"2000","unstructured":"Gerhard A, Neumaier B, Elitok E, et al. In vivo imaging of activated microglia using [11 C]PK11195 and positron emission tomography in patients after ischemic stroke. NeuroReport. 2000;11:2957\u201360.","journal-title":"NeuroReport"},{"key":"3178_CR15","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.neuroimage.2004.09.034","volume":"24","author":"A Gerhard","year":"2005","unstructured":"Gerhard A, Schwarz J, Myers R, et al. Evolution of microglial activation in patients after ischemic stroke: a [11C](R)-PK11195 PET study. Neuroimage. 2005;24:591\u20135.","journal-title":"Neuroimage"},{"key":"3178_CR16","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1212\/WNL.55.7.1052","volume":"55","author":"S Pappata","year":"2000","unstructured":"Pappata S, Levasseur M, Gunn RN, et al. Thalamic microglial activation in ischemic stroke detected in vivo by PET and [11C]PK11195. Neurology. 2000;55:1052\u20134.","journal-title":"Neurology"},{"key":"3178_CR17","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1161\/01.STR.0000226980.95389.0b","volume":"37","author":"CJS Price","year":"2006","unstructured":"Price CJS, Wang D, Menon DK, et al. Intrinsic Activated Microglia Map to the Peri-infarct Zone in the Subacute Phase of Ischemic Stroke. Stroke. 2006;37:1749\u201353.","journal-title":"Stroke"},{"key":"3178_CR18","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1002\/ana.21796","volume":"66","author":"BA Radlinska","year":"2009","unstructured":"Radlinska BA, Ghinani SA, Lyon P, et al. Multimodal microglia imaging of fiber tracts in acute subcortical stroke. Ann Neurol. 2009;66:825\u201332.","journal-title":"Ann Neurol"},{"key":"3178_CR19","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.7150\/thno.24128","volume":"8","author":"B Zinnhardt","year":"2018","unstructured":"Zinnhardt B, Wiesmann M, Honold L, et al. In vivo imaging biomarkers of neuroinflammation in the development and assessment of stroke therapies - towards clinical translation. Theranostics. 2018;8:2603\u201320.","journal-title":"Theranostics"},{"key":"3178_CR20","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1155\/2000\/421719","volume":"12","author":"C Rorden","year":"2000","unstructured":"Rorden C, Brett M. Stereotaxic display of brain lesions. Behav Neurol. 2000;12:191\u2013200.","journal-title":"Behav Neurol"},{"key":"3178_CR21","first-page":"58","volume-title":"Symmetric Atlasing and Model Based Segmentation: An Application to the Hippocampus in Older Adults","author":"G Grabner","year":"2006","unstructured":"Grabner G, Janke AL, Budge MM, et al. Symmetric Atlasing and Model Based Segmentation: An Application to the Hippocampus in Older Adults. 2006. p. 58\u201366."},{"key":"3178_CR22","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jns.2012.06.026","volume":"320","author":"B Guly\u00e1s","year":"2012","unstructured":"Guly\u00e1s B, T\u00f3th M, Schain M, et al. Evolution of microglial activation in ischaemic core and peri-infarct regions after stroke: A PET study with the TSPO molecular imaging biomarker [C]vinpocetine. J Neurol Sci. 2012;320:110\u20137.","journal-title":"J Neurol Sci"},{"key":"3178_CR23","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.neulet.2006.09.093","volume":"411","author":"M Imaizumi","year":"2007","unstructured":"Imaizumi M, Kim H-J, Zoghbi SS, et al. PET imaging with [11C]PBR28 can localize and quantify upregulated peripheral benzodiazepine receptors associated with cerebral ischemia in rat. Neurosci Lett. 2007;411:200\u20135.","journal-title":"Neurosci Lett"},{"key":"3178_CR24","doi-asserted-by":"publisher","unstructured":"Kreisl WC, Mbeo G, Fujita M, et al. Stroke Incidentally Identified Using Improved Positron Emission Tomography for Microglial Activation. Arch Neurol. 66. Epub ahead of print 1 October 2009. https:\/\/doi.org\/10.1001\/archneurol.2009.208.","DOI":"10.1001\/archneurol.2009.208"},{"key":"3178_CR25","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1177\/0271678X17710182","volume":"37","author":"DR Owen","year":"2017","unstructured":"Owen DR, Narayan N, Wells L, et al. Pro-inflammatory activation of primary microglia and macrophages increases 18 kDa translocator protein expression in rodents but not humans. J Cereb Blood Flow Metab. 2017;37:2679\u201390.","journal-title":"J Cereb Blood Flow Metab"},{"key":"3178_CR26","doi-asserted-by":"publisher","first-page":"3440","DOI":"10.1093\/brain\/awz287","volume":"142","author":"E Nutma","year":"2019","unstructured":"Nutma E, Stephenson JA, Gorter RP, et al. A quantitative neuropathological assessment of translocator protein expression in multiple sclerosis. Brain. 2019;142:3440\u201355.","journal-title":"Brain"},{"key":"3178_CR27","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.2967\/jnumed.110.076612","volume":"51","author":"A Thiel","year":"2010","unstructured":"Thiel A, Radlinska BA, Paquette C, et al. The temporal dynamics of poststroke neuroinflammation: a longitudinal diffusion tensor imaging-guided PET study with 11 C-PK11195 in acute subcortical stroke. J Nucl Med. 2010;51:1404\u201312.","journal-title":"J Nucl Med"},{"key":"3178_CR28","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1161\/STROKEAHA.110.598821","volume":"42","author":"A Thiel","year":"2011","unstructured":"Thiel A, Heiss W-D. Imaging of Microglia Activation in Stroke. Stroke. 2011;42:507\u201312.","journal-title":"Stroke"},{"key":"3178_CR29","doi-asserted-by":"publisher","first-page":"11445","DOI":"10.1038\/srep11445","volume":"5","author":"M Sun","year":"2015","unstructured":"Sun M, Deng B, Zhao X, et al. Isoflurane preconditioning provides neuroprotection against stroke by regulating the expression of the TLR4 signalling pathway to alleviate microglial activation. Sci Rep. 2015;5:11445.","journal-title":"Sci Rep"},{"key":"3178_CR30","doi-asserted-by":"publisher","first-page":"59","DOI":"10.5607\/en.2013.22.2.59","volume":"22","author":"H-K Jeong","year":"2013","unstructured":"Jeong H-K, Ji K, Min K, et al. Brain inflammation and microglia: facts and misconceptions. Exp Neurobiol. 2013;22:59\u201367.","journal-title":"Exp Neurobiol"},{"key":"3178_CR31","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1089\/ars.2012.4671","volume":"19","author":"E Parada","year":"2013","unstructured":"Parada E, Egea J, Buendia I, et al. The Microglial \u03b17-Acetylcholine Nicotinic Receptor Is a Key Element in Promoting Neuroprotection by Inducing Heme Oxygenase-1 via Nuclear Factor Erythroid-2-Related Factor 2. Antioxid Redox Signal. 2013;19:1135\u201348.","journal-title":"Antioxid Redox Signal"},{"key":"3178_CR32","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/glia.22363","volume":"61","author":"ED Ponomarev","year":"2013","unstructured":"Ponomarev ED, Veremeyko T, Weiner HL. MicroRNAs are universal regulators of differentiation, activation, and polarization of microglia and macrophages in normal and diseased CNS. Glia. 2013;61:91\u2013103.","journal-title":"Glia"},{"key":"3178_CR33","doi-asserted-by":"publisher","unstructured":"Matejuk A, Ransohoff RM. Crosstalk Between Astrocytes and Microglia: An Overview. Front Immunol. 11. Epub ahead of print 16 July 2020. https:\/\/doi.org\/10.3389\/fimmu.2020.01416.","DOI":"10.3389\/fimmu.2020.01416"},{"key":"3178_CR34","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/nm.1927","volume":"15","author":"A Liesz","year":"2009","unstructured":"Liesz A, Suri-Payer E, Veltkamp C, et al. Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nat Med. 2009;15:192\u20139.","journal-title":"Nat Med"},{"key":"3178_CR35","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s11481-012-9397-5","volume":"8","author":"E Harberts","year":"2013","unstructured":"Harberts E, Datta D, Chen S, et al. Translocator protein 18 kDa (TSPO) expression in multiple sclerosis patients. J Neuroimmune Pharmacol. 2013;8:51\u20137.","journal-title":"J Neuroimmune Pharmacol"},{"key":"3178_CR36","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.bbi.2018.09.018","volume":"75","author":"DS Albrecht","year":"2019","unstructured":"Albrecht DS, Forsberg A, Sandstr\u00f6m A, et al. Brain glial activation in fibromyalgia \u2013 A multi-site positron emission tomography investigation. Brain Behav Immun. 2019;75:72\u201383.","journal-title":"Brain Behav Immun"},{"key":"3178_CR37","doi-asserted-by":"publisher","first-page":"107","DOI":"10.2967\/jnumed.116.178335","volume":"59","author":"DS Albrecht","year":"2018","unstructured":"Albrecht DS, Normandin MD, Shcherbinin S, et al. Pseudoreference Regions for Glial Imaging with 11 C-PBR28: Investigation in 2 Clinical Cohorts. J Nucl Med. 2018;59:107\u201314.","journal-title":"J Nucl Med"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-023-03178-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-023-03178-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-023-03178-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T07:02:52Z","timestamp":1684220572000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-023-03178-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,16]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3178"],"URL":"https:\/\/doi.org\/10.1186\/s12883-023-03178-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1770911\/v1","asserted-by":"object"}]},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,16]]},"assertion":[{"value":"8 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in accordance with the\u00a0Declaration of Helsinki\u00a0and was approved by the local ethics committee (London \u2013 Surrey Borders Research Ethics Committee 17\/LO\/1041).\u00a0To be included, patients had to be able to understand the purpose and risks of the study and provide informed consent and authorisation to use protected health information in accordance with national and local subject privacy regulations and according to the local institutional review board\u2019s (IRB\u2019s)\/ethics committee\u2019s (EC\u2019s) guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Patients have signed a written informed consent for the publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Lucio D\u2019Anna, Graham Searle, Kirsten Harvey report no disclosures. Roland Veltkamp has received fees for consulting and speaker honoraria from AstraZeneca, Bayer, Boehringer Ingelheim, BMS, Pfizer, Daich Sankyo, Portola, Biogen, Medtronic, Morphosys, Amgen as well as research support from Bayer, Boehringer, BMS, Pfizer, Daiichi Sankyo, Medtronic outside of the present work. Paul M. Matthews has received consultancy fees from Roche, Adelphi Communications, Celgene, Neurodiem and Medscape. He has received honoraria or speakers\u2019 fees from Novartis and Biogen and has received research or educational funds from Biogen, Novartis and GlaxoSmithKline.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"193"}}